Takis Biotech

Takis is a biotechnology company located in Rome, Italy. Their team has over 10 years of experience in drug discovery; Takis has contributed to the validation of new targets for the treatment of chronic viral diseases and cancer, and has also contributed to numerous IND/CSA applications in the fields of virology and oncology. Their team is also recognized for conceiving and implementing many innovative technologies aimed at improving in vivo gene transfer, regulation of gene expression, and immunogenicity.Takis' primary focus is on the development of therapeutic cancer vaccines targeting tumor antigens that play a role in the development and maintenance of tumors.Takis plans to enroll its core vaccine candidates through proof-of-concept trials in Phase I and Phase II.Takis Biotech, as a Contract Research Organization (CRO), provides various research services in the fields of oncology, immunology, infectious diseases, and novel preclinical models.